Prospective study of non-vitamin K antagonist oral anticoagulants (NOACs) management in Japanese patients with deep vein thrombosis and pulmonary embolism (DVT/PE)
Not Applicable
- Conditions
- Venous thrombosis
- Registration Number
- JPRN-UMIN000023747
- Lead Sponsor
- Department of Cardiology and Nephrology, Mie University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 1000
Inclusion Criteria
Not provided
Exclusion Criteria
(1) Persons who are initiated or planed warfarin or other Vitamin K antagonists therapy (2) Persons who are initiated or planed non-drug therapy (3) Persons who are not applicable to participate in this study by investigators
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of recurrence of symptomatic venous thromboembolism and hemorrhagic adverse events up to 52 weeks after diagnosis
- Secondary Outcome Measures
Name Time Method 1) Recurrence of symptomatic venous thromboembolism at 52, 104 and 156 weeks 2) Incidence of hemorrhagic adverse events at 52, 104 and 156 weeks 3) Patient background factors of venous thromboembolism 4) Effect and complication of treatment, and recurrence of symptomatic acute pulmonary thromboembolism 5) Effect and complication of treatment, and recurrence of proximal deep vein thrombosis 6) Effect and complication of treatment, and recurrence of isolated calf deep vein thrombosis 7) Adverse events other than bleeding event related to treatment of venous thromboembolism